A novel microneedle-based delivery of NRF2-overexpressing exosomes for scleroderma therapy.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Scleroderma is a chronic autoimmune connective tissue disease characterized by progressive skin fibrosis, vascular dysfunction, and immune dysregulation. Current therapies remain largely ineffective in reversing established fibrosis and are limited by systemic side effects. In this study, we developed a novel therapeutic strategy combining microneedle (MN)-mediated transdermal delivery with NRF2-overexpressing exosomes (NRF2-OE Exos) to locally enhance antioxidant, anti-fibrotic, anti-inflammatory, and pro-angiogenic effects in scleroderma. Exosomes were isolated from NRF2-OE adipose-derived stem cells (ADSCs) and incorporated into GelMA/PEGDA-based dissolvable MNs. These MNs demonstrated excellent mechanical strength, minimal invasiveness, sustained exosome release, and efficient cellular uptake in vitro. Functional assays showed that NRF2-OE Exos-loaded MNs significantly enhanced endothelial tube formation, preserved fibroblast mitochondrial integrity, and promoted macrophage polarization toward a reparative phenotype. In a bleomycin-induced murine scleroderma model, MN treatment reduced dermal thickening, collagen deposition, and α-SMA expression while promoting vascular regeneration and immunomodulation. Mechanistically, transcriptomic analysis revealed that NRF2-OE Exos suppressed pro-fibrotic Wnt and Hippo signaling pathways and activated calcium and cAMP signaling pathwa

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.